JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $60 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating on OrthoPediatrics (NASDAQ:KIDS) and maintained a $60 price target.
September 01, 2023 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics (NASDAQ:KIDS) has had its Market Outperform rating reiterated and its $60 price target maintained by JMP Securities.
The reiteration of the Market Outperform rating and the maintenance of the $60 price target by JMP Securities for OrthoPediatrics indicates a positive outlook for the company. This could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100